Core Scientific expects the secured facility to free about $300 million in restricted cash and improve its financial flexibility. The secured credit gives lenders claims backed by company assets, but the planned cash release is the clearest stated effect.
Freeing cash that was locked away gives Core Scientific more room to run its business. The credit is secured, so lenders have claims backed by company assets. The source gives no borrowing cost or draw details, but the planned cash release is the clearest stated change.
Morgan Stanley is expected to share the facility commitments with 3 other banks. The story gives no fee or profit figures, so it does not show a clear change for the bank.
JPMorgan Chase is expected to share the facility commitments with 3 other banks. The story gives no fee or profit figures, so it does not show a clear change for the bank.
Goldman Sachs is expected to share the facility commitments with 3 other banks. The story gives no fee or profit figures, so it does not show a clear change for the bank.
Get alerts for CORZ
Follow Core Scientific, Inc. (CORZ) free. When we publish a story about it, you get the plain-English explanation as an alert.